{"name":"Ajanta Pharma","slug":"ajanta","ticker":"AJANTPHARM.NS","exchange":"NSE","domain":"ajantapharma.com","description":"Ajanta Pharma Limited (APL) is an Indian multinational pharmaceutical company. The company operates in India, the United States, and over 30 countries across Africa, Southeast Asia, West Asia, and the CIS. It was established in 1973..","hq":"Mumbai, Maharashtra, India","founded":1973,"employees":"~9,628","ceo":"Yogesh M. Agrawal (Managing Director)","sector":"Specialty Generics — Dermatology / Ophthalmology / Cardiovascular","stockPrice":3259.2,"stockChange":136,"stockChangePercent":4.35,"marketCap":"$4.3B","metrics":{"revenue":569429825.6179364,"revenueGrowth":21.5,"grossMargin":78.3,"rdSpend":0,"netIncome":110275693.44,"cash":69404762.5537874,"dividendYield":1.79,"peRatio":38.5,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Doxycycline patent cliff ($10.8M at risk)","drug":"Doxycycline","type":"patent_expiry","sentiment":"negative"},{"date":"2026-06-01","label":"Azithromycin patent cliff ($15.6M at risk)","drug":"Azithromycin","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE","genericName":"EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE","slug":"empagliflozin-metformin-hydrochloride","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE","genericName":"EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE","slug":"empagliflozin-metformin-hydrochloride","phase":"marketed","mechanism":"","indications":[],"catalyst":""}],"recentEvents":[{"date":"2024-02-14","type":"earnings","headline":"Ajanta Pharma reports 14% rise in Q3 FY24 net profit","summary":"Ajanta Pharma's net profit rose 14% to ₹143.4 crore in the third quarter of FY24, driven by strong sales growth.","drugName":"","sentiment":"positive"},{"date":"2023-11-15","type":"deal","headline":"Ajanta Pharma partners with US-based firm for dermatology products","summary":"Ajanta Pharma has partnered with a US-based firm to develop and commercialize a range of dermatology products in the US market.","drugName":"","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPeC01Q2ZpeHBhR2s4czRybm16U3RaWGRFZmpIcTBfd0pHZm95dVJTQVRJRUYtN0FTNnp2WDlha2xtbVJFZk9YU1NORkh6RnRDbnlFSXRKRlcwa19ucHB6RzZIOTN6YW1PTkNsckx6TTRoUWNITmw1WjJGSG5Hb0VFcjB4bjl4WC1udmdB?oc=5","date":"2026-01-19","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Everstone to sell stake in India's Burger King operator Restaurant Brands Asia, sources say - Yahoo Finance Singapore","headline":"Everstone to sell stake in India's Burger King operator Restaurant Brands Asia, sources say","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFA3cTVsei02cDVyLXJxZlV4eXdId043c0YtUWpGYkEyVVNqTi1HNTRnczlCNkVhWXFQbmlFWU03VEkzNG1JYzVZYXJXa3FwcWlfd2tEVEQ5YTR1QkZtblBqU2Q5TFFDUWlQaUxkUkc0anJxX2FZX2V6ag?oc=5","date":"2025-11-25","type":"pipeline","source":"Quiver Quantitative","summary":"Xtrackers Nifty 500 India ETF Holdings - Quiver Quantitative","headline":"Xtrackers Nifty 500 India ETF Holdings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5VRHlsdGluaVJyT3YxVTNFREExa2V6QkFlVDFrTElGZmhfSGxybEpENENBMTBnVng2TG5zZjd2Zl9pSXdsYkNlV1A1cXZwaUF4X2lRVF9n?oc=5","date":"2019-01-28","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Shree Ganesh Remedies Limited (SGRL.BO) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Shree Ganesh Remedies Limited (SGRL.BO) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE1tVmRfaUFvWjY3MnZORzZPQlU5TV9Ydm1BbFBFaEZQNlpvajk3bzVBSmtyOFphcWNKR21TT1Y0TWoySFZDVS14RU1ZOWRtb1hPbU9pbXR5dFpqS3otcEZFOVIxaE1TbjMw?oc=5","date":"2018-03-16","type":"pipeline","source":"Yahoo Finance Australia","summary":"J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) company profile and facts - Yahoo Finance Australia","headline":"J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) company profile and facts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5UbFlSTVU4d0ViZVVIOE5uT2NVdWxTUVc5TVdrS19HRk9LaExTZUJ2RG1KbDQxLTZETlQydUlfR2s0SnBNM2tQckpNMGEyeEphRHo2LXJGWV8yeE1tN2c?oc=5","date":"2017-08-08","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Ajanta Pharma Limited (AJANTPHARM.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Ajanta Pharma Limited (AJANTPHARM.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE94dTB2bUlQRGp3bWlkS0dmN1VwVXI4OXpFaVdyUTNxaHc5TEtMSjFVM1R5clpPRmZHRXA0OTRFX2EyaHlwOENiUzlzdWJQR3Z6eDIyX1VydkNIdw?oc=5","date":"2017-06-07","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Ipca Laboratories Limited (IPCALAB.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Ipca Laboratories Limited (IPCALAB.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE4yZ1oyZHVfV0t4YXo1N1h6SE4ySy01WHUtQzdhbWRVdWFnNkFxUExQdkIybzg1ck5NLUlZMEt0eUV4NmFpWndnSlBWZVpyVlpkR3lWM1BoMA?oc=5","date":"2017-06-06","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Suven Life Sciences Limited (SUVEN.NS) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Suven Life Sciences Limited (SUVEN.NS) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE9YQ3MyTHQ1bHFyYTVMODJaaUFHTm4tOUFUdFVOMjI5SDZtRThhemIxX3hqZVd4TF92Q1lnX2xMZmhrVjdNNnBJb1ktQTh0OXVDRzYxazFn?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance UK","summary":"Strides Pharma Science Limited (STAR.NS) stock price, news, quote and history - Yahoo Finance UK","headline":"Strides Pharma Science Limited (STAR.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9kbWN1aGxhS0h6SkNxZFlJLUl1VldUOWZQU042X0FKRUJNU2NKN0x1V012a3d1RDRMMUxUQmlWMHNBX0lPZEhNQ25EUmNzUkkzTVYwaDRqMmkwaHBxa1E?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Wockhardt Limited (WOCKPHARMA.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Wockhardt Limited (WOCKPHARMA.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE05dUNoNGhBYS1YQU93ZW9pS19aVmdLVDAwaVhpZzV1WUhRUmZMRjhzRkRpZjlnaTI1TzZ4TmV0NGhQMnQ1Uzhnc0daR3gzZ1VuR1cyUFZDQTQxcnBpOHc?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance UK","summary":"Godfrey Phillips India Limited (GODFRYPHLP.NS) stock price, news, quote and history - Yahoo Finance UK","headline":"Godfrey Phillips India Limited (GODFRYPHLP.NS) stock price, news, quote and history","sentiment":"neutral"}],"patents":[{"drugName":"Doxycycline","drugSlug":"doxycycline","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":10800000},{"drugName":"Azithromycin","drugSlug":"azithromycin","patentNumber":"","type":"Patent Cliff","expiryDate":"2026-06-01","territory":"US","annualRevenue":15600000}],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Cipla","Sun Pharma","Dr. Reddy's Laboratories"],"therapeuticFocus":["Dermatology","Ophthalmology","Cardiovascular"],"financials":{"source":"yahoo_finance","revenue":569429846.3364,"revenuePeriod":"2026-03-31","revenueHistory":[{"period":"2026-03-31","value":569429846.3364},{"period":"2025-03-31","value":485390578.294},{"period":"2024-03-31","value":434585438.5066},{"period":"2023-03-31","value":387167934.6048}],"grossProfit":445812464.834,"grossProfitHistory":[{"period":"2026-03-31","value":445812464.834},{"period":"2025-03-31","value":373573531.4116},{"period":"2024-03-31","value":318115091.5298},{"period":"2023-03-31","value":270550344.5146}],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":47944863.988800004,"operatingIncome":292899969.4294,"operatingIncomeHistory":[{"period":"2026-03-31","value":292899969.4294},{"period":"2025-03-31","value":244730585.7996},{"period":"2024-03-31","value":109193822.0536},{"period":"2023-03-31","value":70985800.5424}],"netIncome":110275693.44,"netIncomeHistory":[{"period":"2026-03-31","value":110275693.44},{"period":"2025-03-31","value":96114247.6186},{"period":"2024-03-31","value":85230788.5558},{"period":"2023-03-31","value":61401422.5652}],"eps":84.51,"epsHistory":[{"period":"2026-03-31","value":84.51},{"period":"2025-03-31","value":73.53},{"period":"2024-03-31","value":64.77},{"period":"2023-03-31","value":45.89}],"cash":10783208.4324,"cashHistory":[{"period":"2026-03-31","value":10783208.4324},{"period":"2025-03-31","value":18287385.8288},{"period":"2024-03-31","value":13522348.0526},{"period":"2023-03-31","value":34443401.4842}],"totalAssets":642736031.2616,"totalLiabilities":169982253.785,"totalDebt":27168965.1158,"equity":472753777.4766,"operatingCashflow":55262115.7306,"operatingCashflowHistory":[{"period":"2026-03-31","value":55262115.7306},{"period":"2025-03-31","value":120846913.5602},{"period":"2024-03-31","value":81983085.8418},{"period":"2023-03-31","value":82718257.1314}],"capex":-38132833.5384,"capexHistory":[{"period":"2026-03-31","value":-38132833.5384},{"period":"2025-03-31","value":-33199667.1008},{"period":"2024-03-31","value":-15915831.8534},{"period":"2023-03-31","value":-18221596.3526}],"freeCashflow":17129282.1922,"dividendsPaid":-36520469.2328,"buybacks":0,"employees":0,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":null,"ebit":36494362.2978,"ebitda":41232248.861600004,"period":"2026-03-31","revenue":148458652.2936,"epsBasic":21.35,"netIncome":27850878.258,"rdExpense":null,"epsDiluted":21.34,"grossProfit":116628032.8642,"operatingIncome":76309526.72760001},{"sga":null,"ebit":37980369.038,"ebitda":42524020.0054,"period":"2025-12-31","revenue":143571434.0616,"epsBasic":21.91,"netIncome":28589182.3798,"rdExpense":null,"epsDiluted":21.91,"grossProfit":113677949.2092,"operatingIncome":74618841.617},{"sga":null,"ebit":35128447.4586,"ebitda":39440268.8432,"period":"2025-06-30","revenue":136032795.511,"epsBasic":20.44,"netIncome":26664579.1316,"rdExpense":null,"epsDiluted":20.43,"grossProfit":107223270.5998,"operatingIncome":71280286.7692},{"sga":null,"ebit":28767753.8152,"ebitda":32921889.312400002,"period":"2025-03-31","revenue":122223271.1734,"epsBasic":18,"netIncome":23523392.7124,"rdExpense":null,"epsDiluted":18,"grossProfit":92626361.10260001,"operatingIncome":59255432.5082},{"sga":null,"ebit":32926066.422000002,"ebitda":36682332.2298,"period":"2024-12-31","revenue":119687765.6462,"epsBasic":18.6,"netIncome":24319132.0912,"rdExpense":null,"epsDiluted":18.59,"grossProfit":92765249.9968,"operatingIncome":61317880.3732}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":3259.2,"previousClose":3123.2,"fiftyTwoWeekHigh":3280,"fiftyTwoWeekLow":2329.9,"fiftyTwoWeekRange":"2329.9 - 3280.0","fiftyDayAverage":2888.63,"twoHundredDayAverage":2701.88,"beta":0.2,"enterpriseValue":4209356704.32419,"forwardPE":28.6,"priceToBook":8.99,"priceToSales":7.47,"enterpriseToRevenue":7.39,"enterpriseToEbitda":26.91,"pegRatio":0,"ebitda":156419181.92131892,"ebitdaMargin":27.5,"freeCashflow":90591.06445,"operatingCashflow":55262114.7280937,"totalDebt":27168966.118306305,"debtToEquity":5.7,"currentRatio":2.64,"returnOnAssets":14.8,"returnOnEquity":25.4,"analystRating":"1.3 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":14,"targetMeanPrice":3299.71,"targetHighPrice":3829,"targetLowPrice":2605,"dividendRate":56,"payoutRatio":0.33,"fiveYearAvgDividendYield":0.89,"exDividendDate":1762732800,"insiderHeldPercent":66.4,"institutionHeldPercent":21.8,"sharesOutstanding":124935624,"floatShares":41971173,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":84.64,"epsForward":113.77,"revenuePerShare":436.49,"bookValue":362.4,"officers":[{"age":53,"name":"Mr. Yogesh Mannalal Agrawal M.B.A","title":"MD & Executive Director"},{"age":49,"name":"Mr. Rajesh Mannalal Agrawal M.B.A","title":"Joint MD & Director"},{"age":70,"name":"Mr. Madhusudan Bhagwandas Agrawal B.Sc","title":"Executive Vice Chairman of the Board"},{"age":62,"name":"Mr. Arvind K. Agrawal B Com, F.C.A, L.L.B","title":"Chief Financial Officer"},{"age":null,"name":"Mr. Gaurang Chinubhai Shah","title":"Senior VP of Legal, VP of Corporate Affairs, Company Secretary & Compliance Officer"},{"age":62,"name":"Mr. H. Satish Agrawal M Pharm","title":"President of Technical & Operations"},{"age":null,"name":"Mr. Pourus  Vakil","title":"President of Sales & Marketing"},{"age":null,"name":"Mr. Thampy  Jacob","title":"Senior Vice President of HR"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.ajantapharma.com","phone":"91 22 6060 9000"}}